(Q51450568)

English

Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.

scientific article published in April 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/18382906

Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome. (English)

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/18382906

gestational diabetes

0 references

polycystic ovary syndrome

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

author name string

Robert Thomann

1

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/18382906

Nadia Rossinelli

2

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/18382906

Ulrich Keller

3

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/18382906

Brigitte Frey Tirri

4

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/18382906

Christian De Geyter

5

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/18382906

Juan Ruiz

6

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/18382906

Marius Kränzlin

7

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/18382906

Jardena J Puder

8

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/18382906

publication date

1 April 2008

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/18382906

Gynecological Endocrinology

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/18382906

24

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/18382906

4

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/18382906

199-206

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/18382906

Diagnosis, phenotype, and prevalence of polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

New markers for cardiovascular disease risk in women: impact of endogenous estrogen status and exogenous postmenopausal hormone therapy

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance.

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea.

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

Screening women with polycystic ovary syndrome for metabolic syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

Glucose intolerance in a large cohort of mediterranean women with polycystic ovary syndrome: phenotype and associated factors.

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

Increased prevalence of gestational diabetes mellitus among women with diagnosed polycystic ovary syndrome: a population-based study

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

Impaired glucose tolerance in pregnant women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

Inflammatory markers in women with a recent history of gestational diabetes mellitus

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

The impact of ethnicity on glucose regulation and the metabolic syndrome following gestational diabetes

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

Gestational diabetes diagnostic criteria: long-term maternal follow-up.

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

[Analysis of a 1992 birth sample in Germany. 1: New percentile values of the body weight of newborn infants]

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

Low-grade inflammation and estimates of insulin resistance during the menstrual cycle in lean and overweight women.

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

Menstrual cycle symptoms are associated with changes in low-grade inflammation.

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

Women with polycystic ovary syndrome are sensitive to the TNF-alpha-lowering effect of glucose-induced hyperinsulinaemia.

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

Body composition and adiponectin serum concentrations in adult patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

Prenatal growth restraint followed by catch-up of weight: a hyperinsulinemic pathway to polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

Clinical review: Hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

Growth hormone secretion is impaired but not related to insulin sensitivity in non-obese patients with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

Growth hormone secretion and insulin-like growth factor-1 are related to hyperandrogenism in nonobese patients with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

Evaluation of the quantitative insulin sensitivity check index as an estimate of insulin sensitivity in humans

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

Low sex hormone-binding globulin as a predictive marker for insulin resistance in women with hyperandrogenic syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

Biovariability of plasma adiponectin.

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893398

21 January 2018

Identifiers

10.1080/09513590801893398

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/18382906

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/18382906

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51450568&oldid=1588404195"